Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
Journal of the American Heart Association|March 21, 2025
Long-Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long-Term Survival Study (PEARLS)Saket Girotra, Qiang Li, Mary Vaughan-Sarrazin, et al.
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 7, 2007
The 3a Protein of SARS-coronavirus Induces Apoptosis in Vero E6 CellsMary Y Waye, Patrick W Law, Chi-Hang Wong, et al.
The American Journal of Cardiology|August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Arrhythmia and Electrophysiology|December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial FibrillationJames V Freeman, Peter Shrader, Karen S Pieper, et al.
Heart (British Cardiac Society)|August 10, 2017
Disease understanding in patients newly diagnosed with atrial fibrillationBrystana G Kaufman, Sunghee Kim, Karen Pieper, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2020
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AFBenjamin A Steinberg, DaJuanicia N Holmes, Karen Pieper, et al.
JAMA Cardiology|November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry StudyTaku Inohara, Peter Shrader, Karen Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
Pageof 30